106 related articles for article (PubMed ID: 17257470)
21. [Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)].
Calatayud-Noguera T; Astudillo-González A; Alvarez-Carriles JC; Temprano-Fernández T; Cortés-Velarde M; Oliva-Nacarino P
Rev Neurol; 2009 Jun 1-15; 48(11):582-4. PubMed ID: 19472156
[TBL] [Abstract][Full Text] [Related]
22. Rivastigmine in Parkinson's disease dementia.
Lalli S; Albanese A
Expert Rev Neurother; 2008 Aug; 8(8):1181-8. PubMed ID: 18671661
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis with cholestasis caused by rivastigmine transdermal patch.
Mumoli N; Carmignani G; Luschi R; Cei M; Chiavistelli P
Am J Gastroenterol; 2009 Nov; 104(11):2859-60. PubMed ID: 19888250
[No Abstract] [Full Text] [Related]
24. Maculopapular eruption to rivastigmine's transdermal patch application and successful oral desensitization.
Makris M; Koulouris S; Koti I; Aggelides X; Kalogeromitros D
Allergy; 2010 Jul; 65(7):925-6. PubMed ID: 19889118
[No Abstract] [Full Text] [Related]
25. Anti-Alzheimer drugs: life-threatening adverse effects.
Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
[TBL] [Abstract][Full Text] [Related]
26. Rivastigmine in the treatment of alcohol-induced persisting dementia.
Gibson RC; Barnaby L
West Indian Med J; 2003 Mar; 52(1):59-61. PubMed ID: 12806761
[TBL] [Abstract][Full Text] [Related]
27. One-week dose titration of extended release galantamine in patients with Alzheimer's disease.
Scharre DW; Shiovitz T; Zhu Y; Amatniek J
Alzheimers Dement; 2008 Jan; 4(1):30-7. PubMed ID: 18631948
[TBL] [Abstract][Full Text] [Related]
28. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
29. [Rivastigmine solution prescribing habits in patients with Alzheimer-type dementia in Spain (RIVASOL study)].
González-Gutiérrez JL; Gobartt AL;
Rev Neurol; 2007 Jun 16-30; 44(12):705-10. PubMed ID: 17583861
[TBL] [Abstract][Full Text] [Related]
30. Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease.
Winblad B; Kawata AK; Beusterien KM; Thomas SK; Wimo A; Lane R; Fillit H; Blesa R
Int J Geriatr Psychiatry; 2007 May; 22(5):485-91. PubMed ID: 17407176
[TBL] [Abstract][Full Text] [Related]
31. Enhancing the tolerability of tacrine with propantheline.
Faber RA; Negro PJ
Am J Psychiatry; 1999 Jan; 156(1):156. PubMed ID: 9892315
[No Abstract] [Full Text] [Related]
32. Long-term rivastigmine treatment in a routine clinical setting.
Minthon L; Wallin AK; Eriksson S; Wattmo C; Andreasen N
Acta Neurol Scand; 2009 Mar; 119(3):180-5. PubMed ID: 18759798
[TBL] [Abstract][Full Text] [Related]
33. Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
Int J Geriatr Psychiatry; 2004 Jul; 19(7):641-4. PubMed ID: 15254920
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
Lefèvre G; Sedek G; Jhee SS; Leibowitz MT; Huang HL; Enz A; Maton S; Ereshefsky L; Pommier F; Schmidli H; Appel-Dingemanse S
Clin Pharmacol Ther; 2008 Jan; 83(1):106-14. PubMed ID: 17522596
[TBL] [Abstract][Full Text] [Related]
35. Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.
Blesa R; Ballard C; Orgogozo JM; Lane R; Thomas SK
Neurology; 2007 Jul; 69(4 Suppl 1):S23-8. PubMed ID: 17646620
[TBL] [Abstract][Full Text] [Related]
36. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you!
Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
38. [Rivastigmine against dementia in Parkinson disease?].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
[No Abstract] [Full Text] [Related]
39. Cholinesterase inhibitor initiation in hospital setting.
Wagle KC; Taffet GE; Natali B
J Am Geriatr Soc; 2011 Oct; 59(10):1988-9. PubMed ID: 22091527
[No Abstract] [Full Text] [Related]
40. A rivastigmine patch for dementia.
Med Lett Drugs Ther; 2008 Mar; 50(1282):21-2. PubMed ID: 18356801
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
